Search results
This medication is used to treat certain eye conditions due to inflammation or injury. Fluorometholone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of...
Aug 4, 2023 · Fluorometholone ophthalmic (for the eyes) is a steroid medicine used to treat eye inflammation caused by surgery, injury, or other conditions. Fluorometholone ophthalmic may also be used for purposes not listed in this medication guide.
Nov 14, 2021 · Fluorometholone is a steroid medication that treats allergic reactions and inflammation (swelling) in the eye. It's available as an eye suspension (eye drop) and an ointment.
Jun 2, 2024 · Fluorometholone eye drops are used to treat short-term inflammatory eye conditions. They are usually prescribed by an eye specialist. They contain a corticosteroid (sometimes called a 'steroid') which helps relieve inflammation, redness and irritation.
Feb 1, 2024 · For ophthalmic dosage form (eye drops): Adults—Use one drop in the affected eye two to four times a day. During the first 24 to 48 hours, you may use this medicine every 4 hours, as directed by your doctor.
Dec 10, 2023 · Generic name: Fluorometholone Ophthalmic Suspension [ flure-oh-METH-oh-lone ] Brand names: Fluor-Op, FML Forte. Drug class: Ophthalmic steroids. Medically reviewed by Drugs.com. Last updated on Dec 10, 2023.
Feb 16, 2018 · This drug comes in the forms of eye drops (ophthalmic suspension) and an eye ointment (ophthalmic ointment). Fluorometholone is used to treat certain eye conditions caused by inflammation or...
Fluorometholone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. How to use Fluorometholone Acetate Drops,...
Nov 7, 2022 · FML (fluorometholone) Ophthalmic Suspension is a topical anti-inflammatory agent for ophthalmic (eye) use, for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.
FML FORTE® (fluorometholone ophthalmic suspension 0.25%) suspension is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.
